Still COVIDing Canada

Published by: Global News
Published on: August 25, 2025
By Ari Rabinovitch

Health Canada has approved Moderna’s newly updated COVID-19 vaccine — and for the first time, the vaccines will be “made in Canada.”

The company says having the vaccine available from domestic manufacturers and suppliers creates a critical piece of health resilience to “ensure Canada is ready, not just reactive.”

“With this approval, for the first time ever, mRNA COVID-19 vaccine doses for Canadians will be made in Canada. That’s a remarkable milestone,” Stefan Raos, general manager at Moderna, says in an emailed statement sent to Global News.

Comments closed

vaccines

Health Canada approves updated Pfizer, Moderna COVID-19 vaccines for fall

Published August 22, 2025

Published by: The Canadian Press
Published on: August 22, 2025
By Nicole Ireland

TORONTO – Health Canada has authorized updated COVID-19 vaccines by Pfizer and BioNTech and by Moderna for use this respiratory virus season.

Moderna says it will manufacture vaccine doses for the Canadian market in its new facility in Laval, Quebec and syringes will be filled in Cambridge, Ontario.

News releases from both Pfizer and Moderna say the new mRNA shots will target the LP.8.1 variant, a descendant of Omicron that the World Health Organization was monitoring earlier this year.

Comments closed

vaccines

Moderna Receives Health Canada Approval for Updated COVID-19 Vaccine Targeting SARS-CoV-2 Variant LP.8.1

Published August 22, 2025

Published by: Access Newswire
Published on: August 22, 2025
By Moderna

All 2025 pre-filled syringe doses to be made in Canada, marking a domestic production milestone

CAMBRIDGE, MA / ACCESS Newswire / August 22, 2025 / Moderna announced today that Health Canada has authorized its updated COVID-19 mRNA vaccine, Spikevax®, targeting the SARS-CoV-2 LP.8.1 variant, for individuals aged six months and older. Moderna is on track to deliver the updated vaccine in time for the 2025-2026 vaccination season.

All Spikevax pre-filled syringe (PFS) doses for the Canadian market will now be manufactured domestically, marking the first time Canada’s entire PFS format is produced at home. The drug substance will be produced at Moderna’s new facility in Laval, Quebec, with fill-finish operations completed by Novocol Pharma in Cambridge, Ontario. These Canadian-made doses are expected to be available for this fall.

“This approval is a regulatory milestone and a testament to Canada’s growing leadership in biomanufacturing and public health resilience,” said Stéphane Bancel, Chief Executive Officer of Moderna. “Thanks to Health Canada’s timely and thorough review, we are proud to supply Spikevax doses to communities across the country, including, for the first time this year, doses produced in Canada.”

Comments closed

Alberta

Albertans can get COVID-19 vaccinations for free in B.C.

Published August 21, 2025

Published by: CBC News
Published on: August 21, 2025
By Michelle Bellefontaine

Albertans who don’t qualify for free COVID-19 vaccinations in their home province can get one in British Columbia.

B.C.’s Ministry of Health confirmed that detail in response to a query from CBC News. Canadian residents can get vaccinated due to a reciprocal agreement between all provinces and territories.

“Any publicly funded immunization in B.C. can be provided at no cost to any Canadian travelling within the province,” a statement from the ministry said. “This includes providing publicly funded COVID-19 vaccine to people of Alberta.”

Comments closed

Alberta

Alberta expands COVID-19 shots coverage for health workers, but calls grow for wider access

Published August 20, 2025

Published by: CTV News
Published on: August 20, 2025
By Mark Villani

Calls are growing louder in Alberta for the COVID-19 vaccine to be covered free of charge for all residents, following the province’s decision Tuesday to partially reverse its vaccine policy and expand coverage to some health-care workers.

While the move has been welcomed by workers and unions, public health experts and critics say it doesn’t go far enough, leaving many Albertans uncertain about access to the vaccine.

“The government has now taken a step towards admitting that they had the wrong approach,” said Chris Galloway, executive director at Friends of Medicare.

Comments closed

tick-borne diseases

Tick-borne Rocky Mountain spotted fever spreading in Canada

Published August 20, 2025

Published by: CBC News
Published on: August 20, 2025
By Emily Chung

Quebec has reported a case of the potentially deadly tick-borne disease Rocky Mountain spotted fever that was likely acquired in Ontario or Quebec. The disease was also reported in dogs in Ontario earlier this year.

Here’s what you need to know about preventing, identifying and treating the disease.

Comments closed

Alberta

Alberta government to cover COVID-19 shots for health-care workers in policy reversal

Published August 19, 2025

Published by: The Canadian Press
Published on: August 19, 2025
By Lisa Johnson

EDMONTON – In a partial policy reversal, Alberta’s government said Tuesday it will cover the cost of COVID-19 vaccinations for health-care workers.

Maddison McKee, spokesperson to Primary and Preventative Health Services Minister Adriana LaGrange, said in an email that COVID-19 vaccine coverage will be extended to all health-care workers this fall under the first phase of the province’s vaccination rollout.

“Immunization will remain voluntary,” said McKee.

Comments closed

wildfires

Wildfire smoke far more dangerous to health than thought, say scientists

Published August 19, 2025

Published by: The Guardian
Published on: August 19, 2025
By Ajit Niranjan

Choking smoke spewed by wildfires is far more dangerous than previously thought, a new study has found, with death tolls from short-term exposure to fine particulates underestimated by 93%.

Researchers found that 535 people in Europe died on average each year between 2004 and 2022 as a result of breathing in the tiny toxic particles known as PM2.5 that are released when wildfires rage.

Under standard methods, which assume PM2.5 from wildfires is as deadly as from other sources, such as traffic, they would have expected just 38 deaths a year.

Comments closed

First case of Rocky Mountain spotted fever confirmed in Quebec

Closeup photo of an American dog tick, crawling on the skin of a person. Photo: Jerry Kirkhart. This file is licensed under the Creative Commons Attribution 2.0 Generic license.

Quebec

First case of Rocky Mountain spotted fever confirmed in Quebec

Published August 18, 2025

Published by: Le Devoir
Published on: August 18, 2025
By Florence Morin-Martel

For the first time in Quebec, a person has contracted Rocky Mountain spotted fever, a tick-borne disease that is potentially fatal, a doctor stated on Monday. The patient, recently infected in Estrie, has nevertheless responded well to treatment and has now recovered.

As milder temperatures favour the proliferation of ticks, we expect to see more and more cases in the coming years in Quebec, says Dr. Alex Carignan, infectious disease microbiologist and professor in the Faculty of Medicine and Health Sciences at the University of Sherbrooke. “It is concerning, because it is an infection with significant severity.”

The disease, which is treated with antibiotics, can lead to death if not properly managed. The first symptoms, which appear a few hours or days after a person is bitten, include a high fever, headache, muscle aches, and skin lesions in the form of small red spots.

Comments closed

vaccines

Pfizer Canada and BioNTech Receive Health Canada Approval of LP.8.1 Variant Adapted COVID-19 Vaccine

Published August 18, 2025

Published by: CNW
Published on: August 18, 2025
By Pfizer Canada Inc.

LP.8.1 variant adapted COVID-19 vaccine COMIRNATY is now authorized in Canada for individuals 6 months of age and older. It is expected to be available in Canada in the coming weeks.

KIRKLAND, QC, Aug. 18, 2025 /CNW/ – Pfizer Canada ULC and BioNTech SE (Nasdaq: BNTX) “BioNTech” announced today that Health Canada has authorized the LP.8.1 variant adapted COMIRNATY^® COVID-19 vaccine for individuals aged 6 months and older. The updated COMIRNATY^® vaccine targets the Omicron LP.8.1 variant, one of the most recently circulating SARS-CoV-2 lineages.

This season’s Pfizer and BioNTech COVID-19 vaccine will be available in pharmacies across the country in the fall. The public program operates according to the eligibility criteria determined by each province. If an individual meets these criteria, they will be eligible to receive the vaccine for free.

Comments closed

research

Covid infection ages blood vessels, especially in women

Published August 18, 2025

Published by: European Society of Cardiology
Published on: August 18, 2025

A Covid infection, particularly in women, may lead to blood vessels aging around five years, according to research published in the European Heart Journal [1]…

Comments closed

long COVID

Long COVID left her son with debilitating stomach pain. Why it’s an ‘uphill battle’ for so many kids to get treated

Published August 17, 2025

Published by: Toronto Star
Published on: August 17, 2025
By Kevin Jiang

When Rebecca Lewkowicz’s 10-year-old son, Ethan, first tested positive for COVID-19, the Toronto-based mom of two thought little of it — the boy had only minor symptoms, which went away in a matter of days.

She had little reason to suspect the mild infection in April 2022 would soon derail Ethan’s life trajectory and her plans for his future. Nor did she anticipate she would spend more than a year fighting for her son’s illness to be taken seriously.

“We were lucky because it only took us 13 months to be believed,” Lewkowicz told the Star. ”People (living with long COVID) go two, three, four years without being believed, and children even longer.”

Comments closed

long COVID

Why Canadians with long COVID feel forgotten by the health-care system: ‘The pandemic still isn’t over’

Published August 16, 2025

Published by: Toronto Star
Published on: August 16, 2025
By Kevin Jiang

Parts of Tracey Thompson’s home are papered with notes.

Post-its and sheets of paper are pinned to her fridge and bookshelves, chronicling everything from doctor’s appointments to errands and upcoming tasks — physical reminders of what the 57-year-old says her brain can no longer keep track.

Five years after the dawn of the COVID-19 pandemic, Thompson has become one of the faces of long COVID, her journey chronicled by numerous news articles.

“I understand why more folks aren’t willing to be interviewed because they can garner a lot of negative attention,” she told the Star. “While telling my story can feel repetitive and is often stressful, there are still folks who don’t know what’s wrong with them or what the risks are, so I feel obligated to keep talking.”

Her profile may be higher than most, but Thompson is far from alone.

Comments closed

long COVID

Do you have long COVID? Here’s how to tell, and what we know about the condition so far

Published August 16, 2025

Published by: Toronto Star
Published on: August 16, 2025
By Kevin Jiang

It has been more than five years since the dawn of the COVID-19 pandemic, yet innumerable Canadians are still living with the consequences months or even years after their initial infection.

Much remains unknown about long COVID, or Post COVID Condition (PCC), despite the ailment affecting millions of Canadians and leaving thousands out of work. But as research continues to develop, scientists have gleaned some pieces of the puzzle.

Here’s what we know so far about what long COVID is, why it happens and how to tell if you have it.

Comments closed

Trump regime

Eli Lilly says it will raise drug prices in Europe to ‘make them lower’ in U.S.

Published August 14, 2025

Published by: STAT
Published on: August 14, 2025
By Elaine Chen, Daniel Payne

Eli Lilly said Thursday that it would increase the prices of medicines in Europe and other developed markets “in order to make them lower” in the U.S., an apparent response to the Trump administration’s calls to do so. It singled out the list price of its popular weight-loss drug in the U.K. as part of that effort.

The announcement is among the first moves by a major drugmaker to raise prices abroad in order to lower them in the U.S., in line with President Trump’s agenda. But it’s not clear if these actions would actually increase the amount of revenue that Lilly earns abroad, since governments and private providers that cover drugs often negotiate discounts off the list prices. Lilly did not immediately announce any new price reductions in the U.S.

Comments closed

kakistocracy

‘Distracting the public’: group of health professionals call for RFK Jr to be removed

Published August 13, 2025

Published by: The Guardian
Published on: August 13, 2025
By Melody Schreiber

A grassroots organization of health professionals have released a report outlining major health challenges in the US and calling for the removal of Robert F Kennedy Jr from the US Department of Health and Human Services (HHS).

The report from Defend Public Health, a new organization of about 3,000 health professionals and allies, is an attempt to get ahead of misinformation and lack of information from health officials.

In an effort to keep making progress in public health, Defend Public Health’s report was slated to coincide with that of the anticipated second US report to “make America healthy again” (Maha). The first Maha report was released in May, and a second report was expected this week – but amid turmoil at the health agencies, it has reportedly been delayed for several weeks.

Comments closed

British Columbia

Funding Changes Might Leave BC’s Long-COVID Patients in the Lurch

Published August 12, 2025

Published by: The Tyee
Published on: August 12, 2025
By Michelle Gamage

Upcoming changes to B.C.’s Medical Services Plan could affect how thousands of long-COVID patients access care.

Starting Sept. 1, MSP is capping all online group medical visits to just 20 patients, to “ensure there can still be a one-on-one interaction between each patient and the attending physician,” the Health Ministry told The Tyee.

Most long-COVID care in B.C. is currently delivered through large online group telehealth sessions from the Bowen Island-based BC Centre for Long COVID, ME/CFS, and Fibromyalgia, or BC-CLMF, which currently has over 5,200 patients — with 25 more referred every day, Dr. Ric Arseneau told The Tyee.

Comments closed

research

Lab-made sugar-coated particle blocks Covid-19 infection — Possible new treatment on the horizon

Published August 11, 2025

Published by: Swansea University
Published on: August 11, 2025

Groundbreaking research led by a Swansea University academic has revealed a synthetic glycosystem — a sugar-coated polymer nanoparticle — that can block Covid-19 from infecting human cells, reducing infection rates by nearly 99%.

The glycosystem is a specially designed particle that mimics natural sugars found on human cells. These sugars, known as polysialosides, are made of repeating units of sialic acid — structures that viruses often target to begin infection. By copying this structure, the synthetic molecule acts as a decoy, binding to the virus’s spike protein and preventing it from attaching to real cells.

Unlike vaccines, which trigger immune responses, this molecule acts as a physical shield, offering a novel approach to infection prevention.

Comments closed

Still COVIDing Canada Posts

Still COVIDing Canada Posts

Still COVIDing Canada Posts

Still COVIDing Canada Posts

Still COVIDing Canada Posts

Still COVIDing Canada Posts

Still COVIDing Canada Posts

Still COVIDing Canada Posts

Still COVIDing Canada Posts

Still COVIDing Canada Posts

Still COVIDing Canada Posts

Still COVIDing Canada Posts

Still COVIDing Canada Posts

Still COVIDing Canada Posts

Still COVIDing Canada Posts

Still COVIDing Canada Posts

Still COVIDing Canada Posts

Still COVIDing Canada Posts

Still COVIDing Canada Posts